First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting P2X3 receptors
There’s no risk. Start your trial today to see profiles of Afferent Pharmaceuticals plus 5456 other startups.
Start Free 7 Day Trial Now